HIV treatment-as-prevention research at a crossroads
In light of changing WHO guidelines for HIV treatment, Till Bärnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors' Summary
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 3, 2014
|
| In: |
PLoS medicine
Year: 2014, Jahrgang: 11, Heft: 6, Pages: e1001654 |
| ISSN: | 1549-1676 |
| DOI: | 10.1371/journal.pmed.1001654 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1371/journal.pmed.1001654 Verlag, Volltext: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001654 
|
| Verfasserangaben: | Till Bärnighausen, Nir Eyal, Daniel Wikler |
| Zusammenfassung: | In light of changing WHO guidelines for HIV treatment, Till Bärnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors' Summary |
|---|---|
| Beschreibung: | Gesehen am 05.03.2018 |
| Beschreibung: | Online Resource |
| ISSN: | 1549-1676 |
| DOI: | 10.1371/journal.pmed.1001654 |